NL6717585A - - Google Patents

Info

Publication number
NL6717585A
NL6717585A NL6717585A NL6717585A NL6717585A NL 6717585 A NL6717585 A NL 6717585A NL 6717585 A NL6717585 A NL 6717585A NL 6717585 A NL6717585 A NL 6717585A NL 6717585 A NL6717585 A NL 6717585A
Authority
NL
Netherlands
Application number
NL6717585A
Other versions
NL159282B (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6717585A publication Critical patent/NL6717585A/xx
Publication of NL159282B publication Critical patent/NL159282B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL6717585A 1966-12-23 1967-12-22 PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, AS WELL AS FORMED PRODUCTS OBTAINED BY THE USE THEREOF. NL159282B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60413766A 1966-12-23 1966-12-23
US64111967A 1967-05-25 1967-05-25
US65930867A 1967-08-09 1967-08-09
US68493667A 1967-11-22 1967-11-22

Publications (2)

Publication Number Publication Date
NL6717585A true NL6717585A (en) 1968-06-24
NL159282B NL159282B (en) 1979-02-15

Family

ID=27505067

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6717585A NL159282B (en) 1966-12-23 1967-12-22 PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, AS WELL AS FORMED PRODUCTS OBTAINED BY THE USE THEREOF.

Country Status (7)

Country Link
BE (1) BE708470A (en)
DE (1) DE1617659C3 (en)
FR (2) FR1605535A (en)
GB (1) GB1187830A (en)
IE (1) IE31924B1 (en)
IL (1) IL29066A (en)
NL (1) NL159282B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092875A1 (en) * 1970-06-26 1972-01-28 Maes Roland Interferon stimulants - dialkylaminoalkyl dextran-nucleic acid comple

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063657A1 (en) * 1981-04-29 1982-11-03 Merck & Co. Inc. Topical application of interferon inducers
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
AU692433B2 (en) * 1993-01-13 1998-06-11 Arsinur Burcoglu Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1046770A (en) * 1963-05-14 1966-10-26 James Harrison Stanton Therapeutic composition containing mycelial matter

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092875A1 (en) * 1970-06-26 1972-01-28 Maes Roland Interferon stimulants - dialkylaminoalkyl dextran-nucleic acid comple

Also Published As

Publication number Publication date
GB1187830A (en) 1970-04-15
FR1605535A (en) 1979-02-23
DE1617659A1 (en) 1971-04-01
NL159282B (en) 1979-02-15
DE1617659B2 (en) 1981-05-21
DE1617659C3 (en) 1982-01-21
FR8373M (en) 1971-02-22
IE31924B1 (en) 1973-02-21
IE31924L (en) 1968-06-23
IL29066A (en) 1972-11-28
BE708470A (en) 1968-06-24

Similar Documents

Publication Publication Date Title
FR7270M (en)
FR8373M (en)
AT281852B (en)
AU1534566A (en)
AU1141566A (en)
AU415165B1 (en)
AU414526B2 (en)
AU218666A (en)
AU1393566A (en)
AU1144366A (en)
AU1111066A (en)
BE626310A (en)
BE694015A (en)
BE674987A (en)
BE674882A (en)
BE674792A (en)
BE674777A (en)
BE674713A (en)
BE692369A (en)
BE692551A (en)
BE654686A (en)
BE637138A (en)
BE662818A (en)
BE694547A (en)
BE624223A (en)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: MERCK